Jazz Pharmaceuticals
JAZZ
JAZZ
470 hedge funds and large institutions have $7.04B invested in Jazz Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 146 increasing their positions, 165 reducing their positions, and 56 closing their positions.
Holders
470
Holders Change
–
Holders Change %
0%
% of All Funds
7.41%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
60
Increased
146
Reduced
165
Closed
56
Calls
$11.7M
Puts
$12.4M
Net Calls
-$707K
Net Calls Change
-$7.26M
Top Buyers
| 1 |
SC
1
Samlyn Capital
New York
|
$167M |
| 2 |
AC
2
Armistice Capital
New York
|
$56.5M |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$45.7M |
| 4 |
4
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$48.2M |
| 5 |
5
BlackRock
New York
|
$853M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MFA
526
McClarren Financial Advisors
State College,
Pennsylvania
| – | – | -1 | Closed |
|
527
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
VFA
528
Values First Advisors
Gray,
Tennessee
| – | – | – | – |
|
529
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
MWM
530
Mascoma Wealth Management
Hanover,
New Hampshire
| – | – | – | – |
|